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Abstract
When mouse myoblasts or satellite cells differentiate in culture, the expression of myogenic regulatory factor, MyoD, is
downregulated in a subset of cells that do not differentiate. The mechanism involved in the repression of MyoD expression
remains largely unknown. Here we report that a stress-response pathway repressing MyoD transcription is transiently
activated in mouse-derived C2C12 myoblasts growing under differentiation-promoting conditions. We show that
phosphorylation of the a subunit of the translation initiation factor 2 (eIF2a) is followed by expression of C/EBP homology
protein (CHOP) in some myoblasts. ShRNA-driven knockdown of CHOP expression caused earlier and more robust
differentiation, whereas its constitutive expression delayed differentiation relative to wild type myoblasts. Cells expressing
CHOP did not express the myogenic regulatory factors MyoD and myogenin. These results indicated that CHOP directly
repressed the transcription of the MyoD gene. In support of this view, CHOP associated with upstream regulatory region of
the MyoD gene and its activity reduced histone acetylation at the enhancer region of MyoD. CHOP interacted with histone
deacetylase 1 (HDAC1) in cells. This protein complex may reduce histone acetylation when bound to MyoD regulatory
regions. Overall, our results suggest that the activation of a stress pathway in myoblasts transiently downregulate the
myogenic program.
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Introduction
Satellite cells are the progenitors of adult skeletal muscle. These
cells quiescently reside in a niche between the muscle fiber and the
basal lamina. They become activated in response to damage
or injury; some differentiate and fuse with existing myofibers,
while others sustain satellite cells properties [1]. The myogenic
regulatory factors (MRFs) function in the different stages of the
‘‘life cycle’’ of satellite cells. Myf5 is expressed in quiescent satellite
cells and MyoD is the earliest to be induced when these cells are
activated and enter the cell cycle [2,3,4]. Muscles from MyoD
knockout mice are severely deficient of regenerative capacity after
injury [5]. The absence of MyoD postpones the transition of
satellite cells-derived myoblasts from proliferation to differentia-
tion [6,7,8]. It is believed that a subset of activated satellite cells
lose their capacity to express MyoD in order to preserve a pool of
stem cells for subsequent muscle regeneration. It is not known
which process triggers the loss of MyoD expression and the
mechanism(s) involved are still obscure.
Recent studies which combined genome-wide chromatin
binding and expression profiling of MRFs have identified many
unexpected targets for these factors [9,10]. Among these targets
there were several transcriptional regulators that function in
response to different types of stress. At least two transcription
factors, ATF4 and XBP1 that control certain aspects of the
unfolded protein response (UPR) were found to be induced by
MRFs as part of the myogenic program [10,11]. These results
suggested that myoblasts may be subjected to and are likely to
respond to endoplasmic reticulum (ER) stress during the
differentiation process.
The unfolded protein response (UPR) is an evolutionarily
conserved signaling pathway that is activated by perturbations in
ER homeostasis [12]. In response to the accumulation of unfolded
proteins in the ER, the rate of general translation is attenuated, the
expression of ER resident protein chaperones is induced, the ER
compartment proliferates and ER associated degradation (ERAD)
is activated to eliminate the misfolded proteins. If the prosurvival
efforts are exhausted, ER stress-related apoptosis commences.
Three different transducers mediate UPR; Inositol-requiring
enzyme 1 (IRE1), activating transcription factor-6 (ATF6) and
protein kinase RNA (PKR)-like ER kinase (PERK).
ER stress and UPR were demonstrated to participate in
physiological processes like cell differentiation and maintenance
of cells whose functions include the production and secretion of
proteins, such as immune cells, endocrine and paracrine cells,
hepatocytes, chondrocytes and osteoclasts [13]. ER stress occurs in
skeletal muscle under pathological conditions such as myotonic
dystrophy and chronic muscle atrophy [14,15]. Less is known of
the roles of UPR in normal muscle development and muscle
regeneration. Recent studies by Morishima and colleagues [16,17]
PLoS ONE | www.plosone.org 1 December 2011 | Volume 6 | Issue 12 | e29498indicated that ATF6, and CHOP were induced during myoblast
differentiation in vitro. They suggested that ER stress occurring
during differentiation induced ATF6-mediated apoptosis of
myoblasts [17]. Exposure of myoblast cells to artificial tunicamy-
cin-induced ER stress entailed massive apoptosis of cells, but also
significantly elevated the efficiency of differentiation of the
surviving cells [16].
In the present study we investigated the involvement of CHOP
in the process of myoblast differentiation. We report that transient
activation of stress-response proteins is intrinsic to myoblast
differentiation program. In investigating the role of CHOP, we
unexpectedly found that its transient expression in a subset of cells
prevented their differentiation by repressing the transcription of
myod. Our results indicate that CHOP binds to upstream
transcription regulatory regions of myod thereby repressing its
transcription. Taken in sum, these findings indicate that CHOP
expression is induced in myoblasts to prevent their premature
differentiation.
Results
Stress markers are transiently induced during myoblast
differentiation
Morishima and colleagues [17] reported that the ER stress
sensor ATF6 was specifically activated in myoblasts undergoing
apoptosis. Interestingly, CHOP, another downstream UPR
effector was also activated, and was expressed in surviving
myoblasts. To investigate a possible role of CHOP during muscle
differentiation, we monitored the expression of several stress
markers at several time points after inducing the differentiation of
C2C12 myoblasts. Our results show that phosphorylation of eIF2a
was initiated after 3 hours of myoblast growth in differentiation
medium (DM) and the expression of CHOP and ATF3
transcription factors was induced after 10 and 24 hours,
respectively (Figure 1A). Expression of the two transcription
factors was transient and it diminished at 48 hours. Overall, the
expression of stress markers preceded terminal differentiation (data
not shown). Detection of CHOP by immunostaining indicated that
it was localized in the nuclei of cells growing in DM (Figure 1A).
However, it was expressed in many but not in all cells. The extent
of CHOP expression in differentiating myoblasts was comparable
to its expression following treatment of myoblasts with tapsigargin,
an ER stress inducer. Next, we asked whether the induced
expression of stress proteins was a general response of cells to the
serum starvation conditions that were required the initiation of the
differentiation process. For this purpose, we took advantage of a
fibroblast cell line expressing a MyoD-estrogen receptor fusion
protein (3T3 MyoD:ER) [18]. These cells grow as fibroblasts with
MyoD:ER residing in the cytoplasm. When b estradiol is added to
the medium, it induces nuclear translocation of the MyoD:ER
chimera thus turning cells into myoblasts. We observed that serum
starvation (DM) induced CHOP and ATF3 expression only in
those cells treated b estradiol but not in cells treated with its
solvent ethanol (Figure 1B). We conclude, therefore, that serum
starvation induces CHOP and ATF3 expression in myoblasts but
not in fibroblasts.
Phosphorylation of eIF2a is necessary for the expression
of CHOP and ATF3
Transient phosphorylation of eIF2a at serine 51 indicates that
protein synthesis may be attenuated in cells expressing phosphor-
ylated eIF2a. Indeed, pulse-labeling of proteins in myoblasts at
different growth periods in DM indicated that protein synthesis
was transiently reduced during differentiation (Figure S1). We
asked whether the expression of CHOP and ATF3 was induced
subsequent to the phospohrylation of eIF2a. Embryonic fibroblasts
from the eIF2aS51A knockin mouse (S51A, unphosphorylatable
mutant of eIF2a) and from wild type mouse were infected with a
MyoD:ER-encoding virus [19]. As described above, these cells
become myoblasts following treatment with b estradiol. First, we
confirmed that the mutated eIF2a (S51A) was not phosphorylated
under conditions that induced the phosphorylation of wild type
eIF2a (Figure 2A, upper panel). Next, expression of CHOP and
ATF3 was examined in cells that had either wild type or mutant
eIF2a. We find that CHOP and ATF3 proteins were expressed in
wild type cells, but not in mutated eIF2aS51A cells (Figure 2A,
lower panel). This result indicated that the expression of the two
stress proteins was dependent on the phosphorylation of eIF2a.
The expression of the myogenic markers myogenin and myosin
heavy chain (MyHC), indicated that both cell lines underwent
differentiation in DM (Figure 2B). However, the expression of
myogenin occurred earlier in eIF2aS51A cells than in wild type
cells (Figure 2B). Immunostaining of MyHC confirmed that both
cell lines formed myotubes, though the number of nuclei was
significantly reduced in the mutant cells relative to wild type cells
(Figure 2C). The absence of eIF2a phosphorylation was
correlated, therefore, with earlier expression of myogenin and
with the loss of many cells probably as a result of cell death.
Indeed, FACS analysis revealed massive cell death of eIF2aS51A
expressing myoblasts but not of wild type myoblasts (Figure S2).
CHOP inhibits myoblast differentiation
To investigate the role of CHOP in myoblast differentiation, its
expression was knocked down (Figure 3). As seen in Figure 3A,
CHOP protein levels were significantly reduced in the cells
expressing shRNA. Loss of CHOP expression had two major
outcomes; the expression of myogenin and MyHC were induced
earlier and reached higher levels than their levels in control cells
(Figure 3B, left panel), and the number of nuclei within
differentiated myotubes was significantly increased relative to wild
type cells (Figure 3B, right panel). This result suggested that
CHOP expression inhibited differentiation of myoblasts to
multinucleated myotubes. In a complementary experiment,
C2C12 cells were infected with a retrovirus expressing the wild
type flag-tagged CHOP protein. Exogenous expression of CHOP
delayed and reduced levels of myogenin and MyHC proteins
(Figure 3C, left panel). Exogenous CHOP also reduced the
number of nuclei within myotubes (Figure 3C, right panel).
Interestingly, the levels of the exogenous Flag-CHOP protein
diminished with increasing growth period in DM. Overall these
results indicated that the transient expression of CHOP delayed
myoblasts differentiation.
Expression of CHOP or MyoD and myogenin are mutually
exclusive
C2C12 cells growing for 24 hours in DM were divided into two
populations; mononuclear cells and multinuclear myotubes [4].
CHOP was mostly expressed in the mononucleated cells that were
negative for MyHC expression, and was barely identified in
myotubes expressing MyHC (Figure 4A). The presence of a faint
band representing CHOP in the myotube fraction was likely the
result of residual contamination by mononucleated cells. To
monitor the interrelationship between levels of CHOP expression
and myogenic regulatory factors, C2C12 cells grown for 24 hours
in DM were immunostained for CHOP and MyoD or for CHOP
and myogenin (Figure 4B). Interestingly, CHOP was expressed in
cells that did not express MyoD or myogenin. To inquire whether
CHOP expression was not restricted to only established-myoblast
CHOP Repression of MyoD Transcription
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satellite cells (Figure 4C). More than 95% of the isolated primary
cells were MyoD positive under growth conditions, indicating a
highly enriched myogenic population (data not shown). When
satellite cells were grown in DM, some expressed nuclear CHOP
only while others expressed MyoD but not CHOP (Figure 4C).
Expression of CHOP or MyoD is thus mutually exclusive in both
established myoblasts and primary satellite cells. To investigate
whether CHOP was involved in the cell cycle, its expression and
the expression of cell cycle proteins were analyzed in C2C12 cells
(Figure S3). CHOP expression was not correlated with the
expression of cell cycle proteins (Figure S3A), and its ectopic
expression did not induce the expression of cyclin-dependent
kinase inhibitor, p21 (Figure S3B). Therefore, cells expressing
CHOP are not necessarily quiescent as is expected from ‘‘reserve
cells’’.
An obligatory CHOP repressor prevents the expression of
MyoD
CHOP is a transcription factor that heterodimerizes with basic-
leucine zipper transcription factors: Whereas when paired with
some it represses transcription, its dimerization with others activates
transcription [20,21,22,23]. To determine whether CHOP func-
tions as a transcription activator or a repressor in affecting
differentiating myoblasts, we employed two CHOP chimera
proteins; VP16:CHOP, an obligatory activator and Engrailed:
CHOP, an obligatory repressor. Following confirmation of the
expression of the two chimera proteins (Figure S4), we found that
ectopic expression of VP16:CHOP in myoblasts did not signifi-
cantly affect differentiation (data not shown). However, the
expression of Engrailed:CHOP profoundly inhibited myogenic
differentiation (Figure 5A). Expression of the differentiation markers
myogenin and MyHC was almost completely inhibited (Figure 5A,
left panel) and the number of nuclei within myotubes was
significantly reduced (Figure 5A, right panel). Interestingly, ectopic
Engrailed:CHOP chimera mildly increased the levels of endoge-
nous CHOP and ATF3 proteins. Next, Engrailed:CHOP was
expressed in myoblasts grown for 8 hours in DM (Figure 5B). In
control infected cells, background levels of endogenous nuclear
CHOP with significant levels of nuclear MyoD staining were
observed (Figure 5B, left panel). In contrast, MyoD staining was
absent in cells expressing high levels of CHOP (i.e., Engrailed:-
CHOP) (Figure 5B, right panel). To determine whether the
expression of Engrailed-CHOP affected transcript levels of MyoD,
RNA was isolated from control myoblasts and from myoblasts
expressing Engrailed-CHOP followingtheir 8 hoursgrowth inDM.
Levels of MyoD mRNA were reduced by more than half in cells
expressing Engrailed:CHOP (Figure 5C). These results were in line
with the proposition that by functioning as a transcriptional
repressor in myoblasts CHOP repressed the transcription of MyoD.
CHOP represses the transcription of MyoD
To further inquire how CHOP lowered MyoD transcript levels,
we employed a chimera protein of CHOP and the hormone
Figure 1. Transient expression of stress response proteins during myoblast differentiation. (A) C2C12 myoblasts were differentiated in
DM and proteins were extracted at different time points as indicated. Protein were separated and analyzed by Western blotting (Upper panel). In
another experiment C2C12 myoblasts were differentiated as is described. Cells were fixed and analyzed by immunostaining with an antibody to
CHOP. CHOP in red, DAPI in blue (Lower panel). Bar, 50 mm. (B) 3T3 MyoD:ER cells were differentiated in DM containing ethanol or b estradiol (0.1 mM)
for 24 hours. Proteins were extracted and were analyzed by Western blot with the indicated antibodies (Upper panel). Cells were fixed and were
analyzed by immunostaining with an antibody to CHOP. CHOP is red, DAPI in blue (Lower panel). Bar, 50 mm.
doi:10.1371/journal.pone.0029498.g001
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of b estradiol to the cell medium, the cytoplasmic CHOP:ER
protein was translocated into the nucleus (data not shown).
Importantly, CHOP:ER chimera inhibited differentiation of
C2C12 cells that were grown in the presence of b estradiol as
was apparent by the reduced expression of myogenin and MyHC
relative to their levels in the same cells that were grown in the
presence of ethanol (Figure 6A, right panel). Immunostaining
indicated that translocation of CHOP:ER to cell nuclei following
the addition of b estradiol, largely inhibited the expression of
MyoD (Fig 6A, left panel). Next, we asked how the activation of
CHOP:ER chimera affected MyoD and myogenin mRNA levels
(Figure 6B). The level of myod mRNA was significantly lowered
after 6 hours of growth in the presence of b estradiol relative to
control cells grown for the same period of time in the presence of
ethanol. The level of myogenin mRNA that was significantly
elevated following 24 hours of growth in DM and ethanol
remained low when the same cell line was grown for 24 hours
in DM and b estradiol. This result strongly indicated that temporal
activation of CHOP lowered myod transcript levels and prevented
the subsequent increase in myogenin mRNA levels. Moreover, when
b estradiol was replaced after several hours by ethanol, levels of
MyoD mRNA were restored to the levels that were attained before
CHOP activation (data not shown). Therefore, CHOP-mediated
lowering of the level of MyoD mRNA was reversible. To
determine whether the decrease in MyoD transcripts by CHOP
required newly synthesized proteins, cycloheximide was added
during the activation of CHOP:ER (i.e., addition of b estradiol).
Figure 2. Muscle differentiation of eIF2aS51A knockin cells. Wild type eIF2a and mutated eIF2aS51A fibroblasts were infected with viruses
encoding MyoD:ER protein. (A) Cells were allowed to differentiate in DM and b estradiol (0.1 mM) for the indicated time periods and proteins were
analyzed by Western blot (left panel). Cells were grown in DM and ethanol or b estradiol (0.1 mM) for 24 hours and CHOP and ATF3 proteins were
analyzed by Western blot (right panel). (B) Cell lines were grown as is described in A, and were analyzed by Western blot. (C) Cell lines were grown in
DM for 48 hours. Cells were immunostained with an anti MyHC antibody (MF20); MyHC in red, DAPI in blue. Bar, 50 mm.
doi:10.1371/journal.pone.0029498.g002
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activation of CHOP in the absence or in the presence of
cycloheximide (Figure 6C). Therefore, protein synthesis was not
required for CHOP-mediated lowering of MyoD mRNA levels
raising the likely possibility that CHOP directly repressed MyoD
transcription.
To inquire whether CHOP affected MyoD expression by
interacting directly with transcription regulatory sequences of
MyoD, we used a reporter gene containing promoter and
enhancer sequences of MyoD (6.0 MyoD- nl b gal) that was
stably integrated into the genome of chimera CHOP:ER-
expressing C2C12 myoblasts [24]. A clone of cells expressing b
galactosidase in 40–50% of the cell nuclei of growing myoblasts (in
GM) was isolated and further analyzed. This cell line was grown in
DM for 20 hours in the presence of ethanol (inactive CHOP) or b
estradiol (active CHOP). Nuclear b gal was detected by
colorimetric assay, while CHOP expression was monitored by
immunofluorescent staining (Figure 6D). Our results show that the
number of CHOP-positive nuclei was significantly increased while
the number of b gal positive nuclei decreased in b estradiol-treated
myoblasts relative to control myoblasts that were treated with
ethanol (Figure 6D). Interestingly, the most intense b gal staining
occurred in cells expressing cytoplasmic CHOP (upper panel,
arrows) while cells expressing nuclear CHOP (upper panel,
Figure 3. CHOP inhibits myogenic differentiation. (A) CHOP was knockdown in C2C12 myoblasts by infection of lentivirus expressing ShRNA.
The levels of CHOP protein were analyzed by Western blot of infected myoblasts. (B) Infected myoblasts were grown in DM for the indicated time
periods and myogenic markers were analyzed by Western blot (left panel). Infected myoblasts were grown in DM for 48 hours before cells were
immunostained with anti MyHC antibodies (MF20) (right panel) MyHC in red, DAPI in blue. Percentage of nuclei in myotubes was calculated from
three independent experiments. Mean values and standard errors are presented. Bar, 50 mm. (C) C2C12 myoblasts were infected with retroviruses
encoding a flag-tagged CHOP protein or the parental retrovirus serving as a control. Infected myoblasts were grown in DM for the indicated time
periods and myogenic markers were analyzed by Western blot (left panel). Infected myoblasts were grown in DM for 48 hours before cells were
immunostained with anti MyHC antibodies (MF20) (right panel) MyHC in red, DAPI in blue. Percentage of nuclei in myotubes was calculated from
three independent experiments. Mean values and standard errors are presented. Bar, 50 mm.
doi:10.1371/journal.pone.0029498.g003
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that nuclear CHOP repressed expression driven by transcription
regulatory sequences of the myod gene.
CHOP binds to transcription regulatory sequences of
myod and affects histone acetylation
We next explored the possibility that CHOP affected myod
transcription by associating with its upstream transcription
regulatory sequences. Chromatin Immunoprecipitation (ChIP)
analysis was performed in C2C12 myoblasts stably expressing
Flag-CHOP and grown in DM for 24 hours. The use of
ectopically expressed tagged-CHOP was necessary since the
commercial anti CHOP antibody (9C8) did not immunoprecip-
itate detectable levels of endogenous CHOP protein from
myoblasts grown in DM for 24 hours (data not shown). Therefore,
levels of endogenous CHOP protein are likely to be too low for
detection by IP. The regulatory sequences controlling myod
transcription in myoblast cell lines and in primary satellite cells
are located within 6 kb upstream to the transcription initiation site
[24]. Chromain IP of Flag-CHOP followed by PCR analysis of
fragments that were scattered throughout myod and myogenin
upstream sequences was performed (Figure 7A). Association of
CHOP with several regions of myod upstream sequences, most
prominently around -3Kb was observed. By contrast, association
of CHOP with myogenin upstream sequences could not be detected.
Figure 4. The expression of CHOP and MRFs is mutual exclusive. (A) C2C12 cells were grown in DM for 24 hours and mononucleated cells
were separated from myotubes by selective trypsinization. The two cell populations were subjected to Western blot for analyzing the expression of
CHOP. (B) C2C12 myoblasts were grown in DM for 24 hours, and double stained with antibodies directed against CHOP and myogenin (left panel) or
with antibodies directed against CHOP and MyoD (right panel). DAPI in blue, MyoD and myogenin in green and CHOP in red. Percentage of CHOP
positive, myogenin negative and CHOP positive, MyoD negative relative to the total number of CHOP positive cells was calculated in three
independent experiments. Mean values and standard errors are presented. Bar, 50 mm. (C) The expression of CHOP in primary satellite cells. To induce
their differentiation, satellite cells were grown for 24 hours in GM medium. Cells were analyzed by immunostaining with anti-MyoD (green) and anti-
CHOP (red) antibodies. DAPI staining is in blue. Arrows point at nuclei positive for CHOP staining and negative for MyoD staining. Bar, 50 mm.
doi:10.1371/journal.pone.0029498.g004
CHOP Repression of MyoD Transcription
PLoS ONE | www.plosone.org 6 December 2011 | Volume 6 | Issue 12 | e29498Figure 5. CHOP functions a transcription repressor in myoblasts. (A) A retrovirus encoding a chimera Engrailed-CHOP protein or a retrovirus
containing the parental vector was used to infect C2C12 myoblasts. Infected cells were grown in GM and in DM for the indicated time periods and
proteins were analyzed by Western blot (left panel). Infected myoblasts were grown in DM for 48 hours and were immunostained with an anti-MyHC
antibody (MF20) (right panel). MyHC staining is in red and DAPI is in blue. Percentage of nuclei in myotubes was calculated from three independent
experiments. Mean values and standard errors are presented. Bar, 50 mm. (B) Infected cells described in A were grown in DM for 8 hours and were
analyzed by immunostaining with antibodies directed against CHOP and MyoD. Control infected cells (left panel) and Engrailed-CHOP infected cells
(right panel). Percentage of MyoD-positive nuclei relative to the total number of nuclei was calculated in three independent experiments. Mean
values and standard errors are presented. Bar, 50 mm. (C) C2C12 infected cells as in A were grown in DM for 8 hours and total RNA was then
extracted. MyoD mRNA levels were analyzed by semi-quantitative RT-PCR and quantified by the posphoimager.
doi:10.1371/journal.pone.0029498.g005
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PLoS ONE | www.plosone.org 7 December 2011 | Volume 6 | Issue 12 | e29498Figure 6. CHOP represses MyoD transcription. (A) A C2C12 derived cell line expressing a chimera CHOP:ER protein was constructed as is
described under ‘‘Materials and Methods’’. (A) Myoblasts were grown in the presence of ethanol or b estradiol (0.1 mM) for 8 hours. Cells were
immunostained using anti-MyoD and anti-CHOP antibodies. DAPI in blue, MyoD in green and CHOP in red. Percentage of MyoD-positive nuclei
relative to the total number of nuclei was calculated. Bar, 50 mm. (left panel). In another experiment, cells were grown in the presence of ethanol or b
estradiol (0.1 mM) for 48 hours and proteins were analyzed by Western blot (right panel). (B) The same cells as above were grown in DM in the
presence of ethanol or b estradiol (0.1 mM) for the indicated time periods and mRNA levels of myod and myogenin were determined by semi-
quantitative RT-PCR analysis. (C) The same cells as above were grown in DM and in the presence of ethanol or b estradiol for 6 hours in the absence
or presence of cycloheximide added to cells one hour before the addition of ethanol or b estradiol. (D) A clone of the above cells (i.e., expressing
CHOP:ER) with integrated MyoD reporter gene (6.0 MyoD -nl b Gal) was isolated. These cells were grown in the presence of ethanol or b estradiol for
20 hours. Nuclear expression of b Gal was identified by an enzymatic colorimetric assay, and the expression of CHOP by immunostaining. Arrows
point at b Gal-positive nuclei that are CHOP negative. Percentage of b Gal-positive nuclei out of the total number of nuclei was calculated in two
independent experiments. Mean values and standard errors are presented. Bar, 50 mm.
doi:10.1371/journal.pone.0029498.g006
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sequences and through this interaction it might repress myod
transcription. To investigate the possible involvement of CHOP
with the chromatin of myod regulatory sequences, localized histone
modifications were investigated in the CHOP:ER expressing
myoblast cell line. This cell line was selected for this analysis since
it enables a comparison of nuclear active CHOP with cytoplasmic
inactive CHOP (+/2 b estradiol) under uniform growth
conditions and in the absence of endogenous CHOP expression
(8 hours in DM). Chromatin IP of acetylated histone H4
(‘‘activated chromatin’’) followed by PCR analysis of fragments
that were scattered throughout myod upstream sequences was
performed. Histon H4 acetylation was identified in several regions
upstream to the initiation site of the transcriptionally-active
promoter (Figure 7B) (+ethanol; inactive CHOP:ER). Following
the activation of CHOP:ER (+b estradiol), histone acetylation was
significantly reduced around the 6kb upstream region and less
significantly around the 3Kb upstream region. The 6Kb upstream
region includes the distal regulatory region (DRR) containing myod
enhancer sequences [24]. It is likely, therefore, that nuclear
CHOP protein recruits histone deacetylase to the upstream
regulatory sequences of the myod gene. To investigate the
possibility that CHOP interacts with histone deacetylase (HDAC),
293T cells were transfected with expression vectors of epitope-
tagged CHOP, HDAC1, HDAC3 and HDAC4. CHOP was
immunoprecipitated from cells under mild detergent conditions
and presence or absence of the different HDACs in the protein
complex was assessed (Figure 7C). Interestingly, HDAC1 was
found to be associated with CHOP (Figure 7C, right panel)
whereas HDAC3 and 4 were not detectable in the CHOP-
containing complexes (data not shown). This result is in line with
the idea that histone tail deacetylation by CHOP at MyoD
regulatory sequences involves recruitment of HDAC1. To
investigate the possible involvement of HDACs in MyoD
expression, an HDAC inhibitor, trichostatin A (TSA) was added
to differentiating C2C12 cells (Figure S5). The number of nuclei
within differentiated myotubes was significantly increased in TSA-
treated cells relative to wild type cells. Moreover, unlike control
cells, a significant number of TSA-treated cells co-expressed
CHOP and MyoD, indicating that HDAC inhibitors may have
prevented CHOP-mediated repression of MyoD expression.
Discussion
Temporal activation of stress-induced genes during
myoblast differentiation
Phosphorylation of eIF2a occurring in response to diverse stress
conditions, reduces global translation and allows cells to overcome
the damage and recuperate [25]. The transient phosphorylation of
eIF2a during the in vitro differentiation of myoblasts as observed in
the present study is indicative of stress occurring during this
process. Indeed, our results indicate that this phosphorylation
event is accompanied by transient attenuation of protein synthesis.
Phosphorylated eIF2a is unable to initiate translation from most
mRNA molecules, but selectively translate specific mRNA species
such as mRNA for the transcriptional activator ATF4 [26,27,28].
In this study we were unable to detect ATF4 protein probably due
to technical problems, however we did detect the expression of its
two targets, ATF3 and CHOP [20,29]. The expression of CHOP
and ATF3 occurred in myoblasts and not in fibroblasts grown
under conditions of serum starvation indicating that this response
is integral to the myogenic process. Morishima and colleagues [17]
came to the conclusion that ER stress occurring during myoblast
differentiation induced UPR response transmitted by ATF6. They
showed that a pathway downstream to ATF6 that involves the
activation of caspase12 induced apoptosis of a subset of cells
during myoblast differentiation. Dynlacht and colleagues [10,11]
identified ATF4 and XBP1as probable direct targets of MyoD and
suggested that muscle exhibited properties of an active UPR under
physiological conditions. They proposed the existence of ‘‘ER
stress control checkpoint’’ regulated by the levels of spliced XPB1,
that would halt the differentiation process until ER homeostasis is
reached [11]. Indeed, expression of spliced XBP1 reduced
myotube formation. Together, these studies suggest that all three
UPR sub-pathways are being activated during myoblast differen-
tiation and myofiber maintenance. Activation of each pathway
may exhibit different response to stress; whereas activated ATF6
induces apoptotic cell death of some cells, the induction of
XBP1and of eIF2a-CHOP delays the differentiation process in
others. We show that blockage of the eIF2a-CHOP pathway in
myoblasts derived from eIF2aS51A knockin mouse underwent
massive cell death during the differentiation process. The result
indicates that this pathway may function as a stress control
checkpoint necessary to delay the differentiation process before
damage has been repaired [10,11].
CHOP temporarily delays the differentiation process
The results presented here indicate that the expression of
CHOP delays the differentiation of myoblasts. CHOP is only
expressed in mononucleated undifferentiated cells. At any time
point analyzed by immunostaining, CHOP was detected in a
subset of cells (usually between 40–80% of the cells). By the type of
experiments performed, we cannot resolve whether over time
CHOP is transiently expressed in all or only in a sub-set of cells.
Since the differentiation process is not synchronized in culture we
may assume that CHOP is probably expressed in all myoblasts at
different times. Every cell expressing CHOP did not express the
myogenic regulatory factors, MyoD and myogenin. Therefore,
since CHOP is expressed in a clonal myogenic culture in which all
cells express MyoD under proliferation conditions, we concluded
that upon induction, CHOP represses myogenic gene expression.
The downregulation of MyoD expression in a subset of myoblasts
during in vitro differentiation was reported before and these cells
were termed ‘‘reserve cells’’ [30]. The expression of MyoD was
transiently lost in myoblasts grown in conditions of poor serum,
and was regained when the same cells returned to growth
conditions of high serum. In the present study we used an
inducible chimera CHOP protein and could demonstrate that the
expression of MyoD was regained after the inactivation of CHOP.
Therefore CHOP may play a role in the plasticity of myoblasts to
temporarily delay differentiation and restore more ‘‘stem-like’’
properties. Animal studies should reveal whether CHOP expres-
sion functions as a necessary checkpoint in the differentiation of
embryonic as well as adult myogenic lineage.
CHOP is a repressor of MyoD transcription
CHOP heterodimerizes with other bZIP proteins like C/EBPs,
AP1, CREB, ATF3 and ATF4 [20] and different heterodimers
may activate or repress transcription [21,31,32,33]. Our finding
that the expression of Engrailed-CHOP in myoblasts mimicked
wild type CHOP in inhibiting MyoD expression indicates that
CHOP functioned as a repressor of MyoD. Yet, since endogenous
CHOP was mildly induced by the expression of Engrailed-CHOP,
we cannot exclude the possible involvement of the endogenous
CHOP as an activator. Therefore, in myoblasts, CHOP may
activate the transcription of some genes while repressing the
transcription of others. Several experiments indicate that CHOP
functions as a direct transcriptional repressor of the myod gene.
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Engrailed-CHOP decreased myod transcript levels (Figure 5C),
while knockdown of CHOP entails an increase in the level of myod
transcripts (J.A. unpublished results). Second, an inducible CHOP
protein, CHOP:ER, decreased the levels of myod transcripts upon
its translocation into cell nuclei. Thus, only nuclear CHOP can
affect myod transcript levels. Third, nuclear CHOP:ER reduced the
level of myod mRNA in the presence of the translation inhibitor,
cycloheximide, indicating that CHOP exerted this effect without
the involvement of newly synthesized mediators. Forth, a genome-
integrated myod promoter-enhancer reporter gene was expressed in
myoblasts expressing cytoplasmic transcriptionally inert CHO-
P:ER protein but was not expressed in cells expressing a nuclear
and functional CHOP:ER protein. Therefore, nuclear CHOP
affected MyoD expression via the upstream regulatory sequences
of the gene. A recent study showed that heterodimers of CHOP
with ATF4 repress transcription of aspargine synthetase gene by
association with its transcription regulatory sequences [33].
Figure 7. CHOP associates with MyoD regulatory sequences and affects histone acetylation. (A) A Chromatin IP experiment was
performed on C2C12 cells expressing Flag-CHOP that were grown in DM for 24 hours. Immunoprecipitation of fragmented DNA was performed with
anti-Flag antibodies. PCR amplification of fragments scattered throughout 6 Kb upstream region of the MyoD transcription unit and along 2 Kb
upstream of the myogenin transcription unit was performed. PCR fragments were separated over agarose gels. Gels were scanned and values of band
intensities are presented below. For each set of PCR primers, the value of the input was set to 1. (B) C2C12 cells expressing CHOP:ER chimera were
grown in DM for 8 hours in the presence of ethanol or b estradiol (0.1 mM). Chromatin IP assay was performed on fragmented DNA with anti-
acetylated histone H4 antibody. PCR amplification of fragments scattered along 6 Kb upstream of the MyoD transcription unit was performed. Gels
were scanned and values of band intensities are presented below. For each set of PCR primers, the value of the input was set to 1 (C) 293T cells were
transfected with expression plasmids as indicated. Cells were lysed under mild conditions and extracted proteins were analyzed (left) or
immunoprecipitated with anti-Myc or anti-HA epitope antibodies as indicated (right). Proteins were analyzed by Western blotting as indicated.
doi:10.1371/journal.pone.0029498.g007
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CHOP associated with a certain region of myod regulatory
sequences mostly around 3.0 Kb upstream of the transcriptional
initiation site. By contrast, CHOP was not associated with myogenin
regulatory sequences, indicating that repression of myogenin
transcription by CHOP occurred indirectly, probably through
the direct inhibition of MyoD transcription. Presently, we did not
identify the exact CHOP binding sites at myod regulatory
sequences. Since, the dimerization domain of CHOP is also
necessary for its function (J.A. unpublished results) it is plausible
that CHOP heterodimers repress myod transcription. Identifying
the heterodimeric partner of CHOP should facilitate the search for
putative binding sites at the regulatory sequences. In that respect,
association of C/EBP with a CArG element in the MyoD DRR
was described before [34]. However, binding of CHOP to this
region was not identified by ChIP analysis in the present study.
CHOP deacetylates chromatin at upstream regulatory
sequences of the myod gene
The regulatory sequences necessary for MyoD expression in
satellite cells are included within a 6Kb DNA fragment upstream
to the transcription initiation site [24]. Two regions within these
sequences are sufficient for the expression of MyoD; the
proximal regulatory region (PRR, 275 bp promoter sequences)
and the distal regulatory region (DRR, 750 bp enhancer
sequences located around 6Kb upstream sequences)
[24,34,35,36,37]. In the present study we find that CHOP
associates most significantly with sequences that are located
around 3Kb upstream to the transcription initiation site, found in
between DRR and PRR. This regulatory region was not
identified before, probably because it mediates repression of
myod transcription, unlike activation that is mediated by DRR
and PRR. We also find that CHOP is active in the deacetylation
of histone H4 at two regulatory regions; around 6Kb including
the DRR and around 3Kb upstream sequences. CHOP activity
in histone deacetylation at a distal region (DRR) might be
explained by long-range protein-protein interactions and DNA
looping [38]. Removal of acetyl moieties form histones is one of
several measures to repress transcription [39]. Our results
indicate that CHOP interacts with histone deacetylase1
(HDAC1) in cells, yet further experiments will be necessary to
prove this possibility in myoblasts. Therefore, we would like to
propose a model in which CHOP recruits HDAC1 to MyoD
regulatory sequences and by deacetylation of histone tail
counteracts the sustained activity of enhancer bound (DRR)
histone acetylases [40]. Once, the expression of CHOP is
terminated, myod default transcription is regained. This mecha-
nism may explain the transient nature of MyoD repression.
Interestingly, CHOP activity did not affect K27 histone
trimethylation at several loci, a signature of Polycomb-mediated
repressed heterochromatin (J.A. unpublished result). This result
further indicates that the plasticity of CHOP-mediated repression
is achieved by reducing histone acetylation rather than inducing
a more stable heterochromatic repressive chromatin.
Materials and Methods
Cell culture and satellite cell isolation
C2C12 cells were a gift from Dr. David Yaffe [41]. Cell lines
were maintained in Dulbecco’s modified Eagle’s medium
supplemented with 15% calf serum (HyClone), penicillin, and
streptomycin (growth medium, GM). To induce differentiation, we
used Dulbecco’s modified Eagle’s medium supplemented with
10 mg of insulin per ml and 10 mg of transferrin per ml
(differentiation medium, DM). Fibroblasts from different mice
strains (3T3 wild type, 3T3 eIF2aS51A knockin) were infected
with a retrovirus encoding the MyoD protein and the hormone
binding domain of estrogen receptor (pBABE puro MyoD:ER)
[18]. Myoblast cell lines were isolated following selection with
puromycin (3 mg/ml). Addition of 10
27M b-estradiol to DM
induced translocation of the cytoplasmic chimera protein into the
nucleus and initiation of the myogenic program. Satellite cells
were isolated from the hind legs of 3- to 4-week-old mice. Animal
experiments performed in this study were specifically approved by
the Technion Committee for Care and Use of Laboratory Animals
(IL-020-02-2010; valid until February 2014). The Technion holds
a valid assurance (#A5026-01) of the US Department of Health
and Human Services for humane care and use of laboratory
animals. Muscle tissues were separated from bones and cartilage
dissected and minced, followed by enzymatic dissociation at 37uC
with 0.25% trypsin-EDTA for 30 min. Cells were filtered through
100 mm membrane (Cell strainer, BD Falcon) and were cultured
in rich proliferation medium (BIO-AMF-2, Biological Industries,
Ltd.). To isolate satellite cells from fibroblasts, a preplating
technique was employed [42], which separates myogenic cells
based on their adherence to gelatin-coated flasks. To induce
differentiation, cells were grown in DMEM containing 5% horse
serum (Biological Industries) for up to 4 days.
Retroviral expression vectors and infections
pBABE puro CHOP was described before [43,44]. pCLNCX-
Flag-CHOP: A PCR fragment was isolated from pBABE puro-
CHOP vector and cloned into pCLNCX v.2 using HindIII-ClaI
linkers. pCLNCX-Eng-CHOP: A PCR fragment of CHOP was
inserted into pCS2+ ENG-N vector using XhoI-XbaI linkers. Eng-
CHOP reading frame was PCR isolated and was inserted into
pCLNCX v.2 vector using HindIII-ClaI linkers. pCLNCX-VP16-
CHOP: A PCR fragment of CHOP was inserted into pCS2+
VP16-N vector using XhoI-XbaI linkers. VP16-CHOP was PCR
isolated from pCS2+ VP16-CHOP and was inserted into
pCLNCX v.2 vector using HindIII-ClaI linkers. pBABE puro-
CHOP:ER: CHOP fragment was inserted into pBabepuro:hbER
vector using BamHI-EcoRI linkers. Infection of myoblasts with
replication-defective retroviruses was used to generate cell lines
expressing the different CHOP proteins. Retroviruses were
generated by transfection of retroviral vectors and an expression
vector of vesicular stomatitis virus, the glycoprotein (VSVG), into
viral packaging cells, 293gp, expressing the gag and pol genes
[45].The medium of transfected 293gp cells containing retrovi-
ruses was used to infect cells. Forty-eight hours later, infected cells
were used for the specific experiments. In all cases, infection
efficiency was higher than 80%.
ShRNA-mediated knockdown of proteins
Knockdown of the CHOP protein in myoblasts was achieved by
lentiviral infections of 5 viral vectors that express different shRNA
directed to CHOP mRNA and were purchased from Sigma-
Aldrich (ShRNA MISSION). Viruses were generated by transfec-
tion of 293T cells with MISSION shRNA vectors and DNRF
vector encoding for gag- pol, and CMV-VSVG encoding for
envelop glycoprotein of vesicular stomatitis virus. The medium of
transfected 293T cells containing lentiviruses was used to infect
myoblasts that were further selected with puromycin (3 mg/ml).
Knockdown efficiency was analyzed by western blotting. Viral
particles that caused maximal repression of CHOP expression
relative to control particles were chosen for the knockdown
experiments.
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The procedure was performed as described [46]. The following
antibodies were used in the immunoblatting: anti CHOP
monoclonal (9C8); 1:100, anti ATF3 (Santa cruz);1:500, anti
eIF2a (phospho S51, Cell signaling); 1:1000, anti MyoD (Santa
Cruz #760); 1:1000, anti myogenin, (F5D); 1:1000, anti MyHC
(MF20); 1:1000, anti Flag (M2, Sigma-Aldrich); 1:1000, anti a
tubulin (Sigma- Aldrich); 1:10000. Proteins were visualized using
the enhanced chemiluminescence kit of Pierce Inc.
Immunostaining
Cells were fixed and immunostained as described [47]. The
primary antibodies used were anti-MyHC (MF-20), anti-CHOP
(9C8), anti MyoD (Santa cruz#760), anti myogenin (F5D), anti-
estrogen receptor (Santa cruz). Cells were exposed to secondary
fluorescently-labeled antibody and DAPI (1 mg/ml). The immu-
nochemically stained cells were viewed at x200 or x650
magnification under a fluorescence microscope and photographed
with a digital camera.
Semi quantitative RT-PCR analysis of RNA
RNA extraction, reverse transcriptase and PCR reactions were
performed as described [46]. The following pairs of primers were
used: MyoD: F; 59-AGCACTACAGTGGCGACTCA-39 R;5 9-
CTGGGTTCCCTGTTCTGTGT-39 Myogenin: F; 59-CTA-
CAGGCCTTGCTCAGCTC-39 R; 59-GGCAACAGACATAT-
CCTCCA-39 GAPDH: F; 59 ACA TCA TCC CTG CAT CC 39
R; 59 CTC CTT GGA GGC CAT GT 39.
Separation of mononucleated cells from myotubes
In general, myotubes were separated from mononucleated cells
by selective trypsinization as is described [4]. Briefly, C2C12 cells
that were grown in DM for 24 hours were trypsinized with 0.05%
trypsin for 0.5 minute which specifically detached myotubes and
leaving undifferentiated mononucleated cells adherent to the dish.
Chromatin IP analysis
Chromatin immunoprecipitation (IP) assay was performed after
Tapscott and colleagues [9]. The cells used for ChIP assays were
C2C12 myoblasts expressing Flag-CHOP to identify CHOP
binding to DNA and C2C12 myoblasts expressing CHOP:ER to
identify histone H4 acetylation. Antibodies (5 ml) used for
immunoprecipitations were anti-Flag (Sigma), anti-acetyl H4
antiserum (Upstate), or IgG (Santa cruz). PCR reactions were
performed with cold nucleotides and were analyzed over agarose
gels. For the input samples, 2 ng DNA was used and 40 cycles
were performed. For CHOP IPs and acetylated H4 IPs 1% of the
IP sample was used and 40 cycles were performed. The following
pairs of primers were used:
MyoD -6 to -5 Kb (-5586) F: GCCCGCAGTAGCAAAGTAAG
(-5315) R: ATAGGTGGCCCCTTTGATTT. Size: 271 bp.
MyoD -5 to -4Kb (-4488) F: CAGCTGAGGTTCCAAAAAGG
(-4362) R: ATGGATGTGGGGTTCATCAT. Size: 126 bp.
MyoD -4 to -3Kb (-3327) F: CAGGGTGCTGGTGCTCTTAT
(-3121) R: AAACCGGCAGGAATAGGACT Size: 206 bp. MyoD
-3 to -2Kb (-2631) F: CTTTGCCCGCATGTAAGTTT (-2367) R:
GGCCACTCAGATGGTTGTTT. Size: 264 bp. MyoD -2 to
-1Kb (-1534) F: CCTGGGTGAGTCTGATGGAT (-1293) R:
TTGTGGGATCTCTGGCTCTC. Size: 241 bp. MyoD -1 Kb to
start. (-586) F: AATAGCACTGCCACCGATTC (-407) R:
GATTGCAGGAGGTTTGGAGA. Size: 179 bp. Myogenin -1.5
to -0.7Kb (-1487) F: GCCCAGGACAGACAAATGAT (-1251) R:
AGCCTCACAAGAGGCAGCTA. Size: 236 bp. Myogenin -0.7
Kb to start. (-442) F: GGATTTTCAAGACCCCTTCC (-221) R:
CCGTCGGCTGTAATTTGATT. Size: 221 bp.
(The first nucleotide numbering of each primer is relative to the
transcription start site.)
Co-immunoprecipitation
Proteins were extracted in lysis buffer (20mM Tris pH7.5,
150mM NaCl, 1mM EDTA, 1mM EGTA, 1% Tritin X-100, a
cocktail of protease inhibitors). 500 mg of proteins were incubated
with 40 m 50% protein A/G beads for an hour (pre-clearing) and
then with protein A/G beads that were pre incubated with the
indicated antibodies (5 mg each) for 4 hours. Beads were washes 5
times in lysis buffer (1 ml). Proteins were released from beads in
SDS sample buffer and were analyzed by western blotting.
Supporting Information
Figure S1 Translational switch during myoblast differ-
entiation. C2C12 myoblasts were differentiated in DM for the
indicated time periods. Two hours before protein extraction,
cells were metabolically-labeled with 100 mCi/ml [
35S] methio-
nine. Identical total amount of proteins of each sample were
loaded and were separated over SDS-PAGE. Gel was exposed to
X ray films.
(TIF)
Figure S2 Significant cell death of eIF2aS51A myoblasts.
Mutated eIF2aS51A and wild type fibroblasts were infected with
viruses encoding the MyoD:ER protein. Cell lines were grown in
DM for the indicated time periods. Cells were fixed and DNA was
labeled with propidium iodide, and cells were FACS analyzed.
DNA content was quantified using ModFit software (Becton
Dickinson).
(TIF)
Figure S3 CHOP does not induce the expression of p21
CDK inhibitor. (A) C2C12 cells were differentiated for 24 hours
in DM. Upper panel: Cells double-stained with antibodies against
CHOP and p21 (Santa Cruz). Arrows point at nuclei positive for
CHOP staining and negative for p21 staining. Lower panel: Cells
double-stained with antibodies against CHOP and phospho
Histone H3 (Cell signaling). Arrow points at CHOP
+/pHis H3
+
cell. Bar, 50 mm. (B) Control C2C12 ER and C2C12 CHOP:ER
cells were grown for 8 hours and 24 hours in DM and in the
presence of ethanol or b estradiol (0.1 mM). Levels of p21 protein
were analyzed by Western blotting.
(TIF)
Figure S4 Expression of CHOP chimera proteins. 293T
cells were transfected with retroviral expression vectors encoding
for wt CHOP, VP16-CHOP and Eng-CHOP. Twenty four hours
after transfection, cells were lysed and protein extracts were
analyzed by Western blot with anti-CHOP antibodies.
(TIF)
Figure S5 Treatment of C2C12 cells with trichostatin A
(TSA) increases co-expression of CHOP and MyoD.
C2C12 cells were grown for 10 hours in DM and in the absence
or presence of trichostatin A (50 nM). Following that period,
medium was replaced by DM. (A) Cells were grown for additional
38 hours (total 48h in DM) and were then immunostained with
antibodies against NyHC. Percentage of nuclei within myotubes
was calculated from two microscopic fields. Bar, 50 mm. (B) Cells
were grown for additional 14 hours (total 24h in DM) and were
immunostained with antibodies against CHOP and MyoD.
CHOP Repression of MyoD Transcription
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+/MyoD
+ nuclei was calculated from 100
CHOP positive nuclei. Bar, 50 mm.
(TIF)
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